Key Health Care Antitrust and Competition Takeaways from ASHEcon 2025
Focusing on the intersection of academic research and litigation matters, Daniel Shack and Annabelle Fowler highlight key research developments and discussion...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA experts provide consultation and expert testimony in healthcare matters related to attempted monopolization or collusion and price fixing. Our experts use cutting-edge theory and empirical analyses to distinguish aggressive competition that is procompetitive from business practices that hinder competition or to assess the plausibility of collusion claims and to perform statistical analyses to distinguish between competitive and anti-competitive pricing and payment.
Focusing on the intersection of academic research and litigation matters, Daniel Shack and Annabelle Fowler highlight key research developments and discussion...
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...